Literature DB >> 1201976

Cephaloridine, cephalothin and the kidney.

R D Foord.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 1201976     DOI： 10.1093/jac/1.suppl_3.119

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  12 in total

Review 1.  [Comprehension of the side effect profile of a new substance under development. Experimental toxicological aspects].

Authors:  D Mayer; C Cojocel
Journal:  Infection       Date:  1991       Impact factor: 3.553

Review 2.  Pharmacological properties of cephalosporins.

Authors:  W Christ
Journal:  Infection       Date:  1991       Impact factor: 3.553

Review 3.  Antibiotic therapy in aging patients.

Authors:  S R Norrby
Journal:  Bull N Y Acad Med       Date:  1987 Jul-Aug

4.  Effect of timing of cefuroxime dosage on its protection of rats against gentamicin nephrotoxicity.

Authors:  K Capel-Edwards; R M Atkinson; J M Wheeldon; D A Pratt; G G Patterson; I W Harman; R D Foord
Journal:  Infection       Date:  1980       Impact factor: 3.553

Review 5.  Side effects of cephalosporins.

Authors:  S R Norrby
Journal:  Drugs       Date:  1987       Impact factor: 9.546

6.  The pharmacokinetics of ceftazidime in patients with impaired renal function and concurrent frusemide therapy.

Authors:  R A Walstad; K Dahl; K B Hellum; E Thurmann-Nielsen
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

Review 7.  Adverse reactions and interactions with newer cephalosporin and cephamycin antibiotics.

Authors:  S R Norrby
Journal:  Med Toxicol       Date:  1986 Jan-Feb

8.  [Nephrotoxicity of cefsulodin: experimental studies in animals (author's transl)].

Authors:  G Burmann; G Mertens; E Schulz; K Sack
Journal:  Infection       Date:  1981       Impact factor: 3.553

9.  Cephaloridine-induced nephrotoxicity in the Fischer 344 rat: proton NMR spectroscopic studies of urine and plasma in relation to conventional clinical chemical and histopathological assessments of nephronal damage.

Authors:  M L Anthony; K P Gartland; C R Beddell; J C Lindon; J K Nicholson
Journal:  Arch Toxicol       Date:  1992       Impact factor: 5.153

10.  Assessment of the nephrotoxic potential of ceftazidime and a ceftazidime/tobramycin combination in volunteers.

Authors:  A W Mondorf; F T Heynold; J E Scherberich; H Hess; W Schoeppe
Journal:  Infection       Date:  1983       Impact factor: 3.553
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.